Hagop Kantarjian1, Robert Chapman2. Show Affiliations » 1. Leukemia Department, MD Anderson Cancer Center, Houston, Texas. 2. Division of Hematology and Medical Oncology, Josephine Ford Cancer Institute, Detroit, Michigan.
Abstract
Mesh： See more » Antineoplastic Agents/economicsDrug Costs/legislation & jurisprudenceEligibility Determination/economicsGovernment RegulationHealth Services Accessibility/economicsHealth Services Accessibility/legislation & jurisprudenceHealth Services Misuse/economicsHumansMedicaid/economicsMedicaid/legislation & jurisprudenceMedically UninsuredMedicare Part B/economicsMedicare Part B/legislation & jurisprudenceSafety-net Providers/economicsUnited StatesUnited States Department of Veterans Affairs/economicsUnited States Department of Veterans Affairs/legislation & jurisprudence
Substances： See more » Antineoplastic Agents
Year: 2015 PMID： 26313652 DOI： 10.1001/jamaoncol.2015.2168
Source DB: PubMed Journal: JAMA Oncol ISSN： 2374-2437 Impact factor: 31.777